QUOTIENT SCIENCES LIMITED

Quotient Sciences Limited is a global Contract Research, Development, and Manufacturing Organization (CRDMO) headquartered in Nottingham, UK. With over 30 years of experience, Quotient Sciences specializes in accelerating drug development by providing integrated services across the entire development lifecycle, helping pharmaceutical and biotechnology companies bring therapies to patients faster. The company offers end-to-end solutions that span formulation development, clinical pharmacology, translational pharmaceutics, and commercial drug product manufacturing. Its integrated approach ensures that every stage of drug development, from first-in-human studies to large-scale production, is streamlined for efficiency, quality, and compliance. Quotient Sciences’ Formulation Development services focus on creating tailored drug formulations optimized for clinical and commercial success. Their Clinical Pharmacology expertise enables early decision-making with first-in-human studies, dose escalation, and pharmacokinetic evaluations. The company’s Translational Pharmaceutics® platform is a unique innovation that combines real-time cGMP manufacturing with clinical activities, reducing development timelines and accelerating go/no-go decisions. In addition, Quotient Sciences provides Commercial Manufacturing capabilities, offering scalable solutions for drug products with strict adherence to GMP standards. Their integrated service model allows seamless transitions between development and manufacturing stages, supporting both small molecule and peptide drug programs. Committed to improving global health, Quotient Sciences works closely with clients to navigate the complexities of drug development, ensuring quality, compliance, and speed at every step. By combining scientific expertise with innovative technologies, the company empowers pharmaceutical and biotech companies to transform molecules into effective therapies for patients worldwide.